|
|
Volumn 57, Issue 5, 1995, Pages 518-524
|
|
Stereoselective disposition of carvedilol is determined by CYP2D6
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARVEDILOL;
CYTOCHROME P450 ISOENZYME;
DEBRISOQUINE;
DRUG METABOLITE;
MEPHENYTOIN;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CLEARANCE;
DRUG DISPOSITION;
DRUG METABOLISM;
HUMAN;
HUMAN EXPERIMENT;
ISOMER;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PHARMACOGENETICS;
PHENOTYPE;
PRIORITY JOURNAL;
STEREOSPECIFICITY;
ADRENERGIC ALPHA-ANTAGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
CARBAZOLES;
CYTOCHROME P-450 CYP2D6;
CYTOCHROME P-450 ENZYME SYSTEM;
DEBRISOQUIN;
HALF-LIFE;
HUMANS;
MEPHENYTOIN;
METABOLIC CLEARANCE RATE;
MIXED FUNCTION OXYGENASES;
PHARMACOGENETICS;
PHENOTYPE;
PROPANOLAMINES;
STEREOISOMERISM;
|
|
EID: 0029035966
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1016/0009-9236(95)90036-5 Document Type: Article |
|
Times cited : (141)
|
|
References (19)
|
